MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association.

TO THE EDITOR:Despite the astounding twenty-first century growth in informatics science and technology, individuals with rare disorders often continue to suffer morbidity and anxiety as a result of inaccurate diagnosis or delayed treatment.[1][1] Although 86% of patients with Gaucher disease (GD)